journal article·2025-08-07Open access

Mutation Rates and Fitness Genes in Staphylococcus aureus Treated with the Medicinal Plant Synadenium glaucescens

Zaituni Msengwa, Martin Saxtorph Bojer, Frank Rwegoshora, James Mwesongo, Magesa Mafuru, Faith Philemon Mabiki, Beda John Mwang’onde, Madundo Mkumbukwa Mtambo, Lughano Jeremy Kusiluka, Henrik Christensen, Robinson Hammerthon Mdegela, John Elmerdahl Olsen

Applied Sciences· Volume 15· Issue 15

Abstract

Extracts, fractions and the pure compound epifriedelanol of the medicinal plant Synadenium glaucescens have antibacterial properties. Herbal products are generally considered less prone to resistance development than conventional antimicrobials, as they contain multiple compounds, which makes bacteria less likely to develop resistance. However, data supporting this notion are lacking. This study evaluated the development of resistance in Staphylococcus aureus subjected to extract, fractions and epifriedelanol of S. glaucescens. It also identified S. aureus fitness genes contributing to intrinsic resistance to extract of S. glaucescens. Fluctuation and gradient concentration assays were used to determine mutation rates and growth adaptation, respectively, which were lower following exposure to growth in crude extract than the pure compound epifriedelanol. By subjecting 1920 single gene mutants from the Nebraska Transposon Mutant Library to growth in the presence of extract of S. glaucescens, 12 genes were identified as important for natural resistance in S. aureus JE2; however, only mutation in the hemB gene decreased the minimum inhibitory concentration by greater than 4-fold (64-fold). In conclusion, purifying active antimicrobial compounds from S. glaucescens and using them as antibacterial substances as an alternative to crude extract increased the risk of resistance development. Further, the gene hemB appears to have a significant role in the natural resistance to the extracts obtained from S. glaucescens in this study.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Complementary and Alternative Medicine Studies · Plant-based Medicinal Research · Herbal Medicine Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Physics, Sokoine University of Agriculture, Morogoro P.O. Box 3038, Tanzania

Department of Veterinary and Animal Sciences, University of Copenhagen, Stigbøjlen 4, 1870 Frederiksberg C, Denmark

Department of Biological and Pre-Clinical Studies, Institute of Traditional Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania

Department of Biosciences, Sokoine University of Agriculture, Morogoro P.O. Box 3038, Tanzania

Department of Clinical Pharmacology and Therapeutics, Hubert Kairuki Memorial University, 322 Regent Estate, Dar es Salaam P.O. Box 65300, Tanzania

Department of Administration, Tanzania Industrial Research and Development Organisation, Dar es Salaam P.O. Box 23235, Tanzania

Department of Microbiology and Parasitology, School of Medicine and Dentistry, The University of Dodoma, Dodoma P.O. Box 259, Tanzania

Department of Veterinary Medicine and Public Health, Sokoine University of Agriculture, Morogoro P.O. Box 3021, Tanzania

Funding

Danish International Development Agency (DANIDA)

References (36)

Show source-provided references
1. Salam, A., Al-Amin, Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.10.20944/preprints202305.0555.v1 ↗
2. EClinical Medicine (2021). Antimicrobial resistance: A top ten global public health threat. eClinicalMedicine, 41, 101221.10.1016/j.eclinm.2021.101221 ↗
3. O’Neill, J. (2021, November 14). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations: The Review on Antimicrobial Resistance. Available online: https://amr-review.org.
4. Lade, H., and Kim, J.-S. (2021). Bacterial targets of antibiotics in methicillin-resistant Staphylococcus aureus. Antibiotics, 10.10.3390/antibiotics10040398 ↗
5. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis10.1016/S0140-6736(21)02724-0 ↗
6. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro10.1186/s12866-019-1573-9 ↗
7. A Genetic Resource for Rapid and Comprehensive Phenotype10.1128/mBio.00537-12 ↗
8. WHO (2021, November 14). Antimicrobial Resistance. Available online: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
9. Guo, Y., Song, G., Sun, M., Wang, J., and Wang, Y. (2020). Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol., 10.10.3389/fcimb.2020.00107 ↗
10. Finding novel antibiotic substances from medicinal plants—Antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria10.1556/1886.2017.00001 ↗
11. Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., and Bezirtzoglou, E. (2021). Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives. Microorganisms, 9.10.3390/microorganisms9102041 ↗
12. Innocent, E., Marealle, A.I., Imming, P., and Moeller, L. (2022). An Annotated Inventory of Tanzanian Medicinal Plants Bacterial Infections. Plants, 11.10.3390/plants11070931 ↗
13. Bacterial development of resistance to botanical antimicrobials10.15310/2334-3591.1065 ↗
14. Genotoxicity induced by medicinal plants10.1186/s42269-022-00803-2 ↗
15. Epifriedelanol is the key compound to antibacterial effects of extracts of Synadenium glaucescens (Pax) against medically important bacteria10.3389/fitd.2022.1104543 ↗
16. Schijffelen, M.J., Boel, C.H.E., Van Strijp, J.A.G., and Fluit, A.C. (2010). Whole genome analysis of a livestock-associated methicillin-resistant. BMC Genom., 11.10.1186/1471-2164-11-376 ↗
17. Characterization of a Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus10.1016/j.jinf.2006.03.011 ↗
18. Isolation and toxicity evaluation of feruloyl ester and other triterpenoids from Synadenium glaucescens Pax10.31254/phyto.2022.11506 ↗
19. NCCLS (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents, NCCLS. NCCLS document M26-A.
20. Measuring microbial mutation rates with the fluctuation assay
21. National Institute of Health (NIH) Public Access10.1016/S0076-6879(05)09012-9 ↗
22. Gantzhorn, M.R., Olsen, J.E., and Thomsen, L.E. (2015). Importance of sigma factor mutations in increased triclosan resistance in Salmonella Typhimurium. BMC Microbiol., 15.10.1186/s12866-015-0444-2 ↗
23. Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus10.1016/j.ijantimicag.2017.08.024 ↗
24. Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis10.1128/AAC.16.5.655 ↗
25. Antibiotic combinations: Should they be tested?10.1128/CMR.1.2.139 ↗
26. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate10.1128/JCM.41.4.1520-1524.2003 ↗
27. Biocide resistance mechanisms10.1016/S0964-8305(02)00097-5 ↗
28. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly10.1128/jb.179.15.4706-4712.1997 ↗
29. Proctor, R., Fischetti, V.A., Novick, R.P., Ferretti, J.J., Portnoy, D.A., Braunstein, M., and Rood, J.I. (2019). Respiration and Small Colony Variants of Staphylococcus aureus. Microbiol. Spectr., 7.10.1128/microbiolspec.GPP3-0069-2019 ↗
30. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus10.1128/AAC.18.5.722 ↗
31. Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells10.1128/AAC.01468-10 ↗
32. Vestergaard, M., Roshanak, S., and Ingmer, H. (2021). Targeting the ATP synthase in Staphylococcus aureus small colony variants, Streptococcus pyogenes and pathogenic fungi. Antibiotics, 10.10.3390/antibiotics10040376 ↗
33. Staphylococcus aureus phenotype switching: An effective bacterial strategy to escape host immune response and establish a chronic infection10.1002/emmm.201000115 ↗
34. Antibacterial Effects Of Single And Combined Crude Extracts Of Synadenium glaucescens And Commiphora swynnertonii
35. Zhang, P., Wright, J.A., Osman, A.A., and Nair, S.P. (2017). An aroD ochre mutation results in a Staphylococcus aureus small colony variant that can undergo phenotypic switching via two alternative mechanisms. Front. Microbiol., 8.10.3389/fmicb.2017.01001 ↗
36. Proctor, R.A., Kriegeskorte, A., Kahl, B.C., Becker, K., Lãffler, B., and Peters, G. (2014). Staphylococcus aureus Small Colony Variants (SCVs): A road map for the metabolic pathways involved in persistent infections. Front. Cell. Infect. Microbiol., 4.10.3389/fcimb.2014.00099 ↗